Over-the-counter heartburn drug Zantac pulled in US, Canada

Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.

The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.

In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor.

Several drugstore chains have already removed Zantac and generic versions from store shelves.

Explore further

CVS stops sale of heartburn drugs with suspect contaminant

© 2019 The Associated Press. All rights reserved.

Citation: Over-the-counter heartburn drug Zantac pulled in US, Canada (2019, October 18) retrieved 17 September 2021 from https://medicalxpress.com/news/2019-10-over-the-counter-heartburn-drug-zantac-canada.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors